PROTECT 12 Month RCT Data – Impact of a Unique EDOF Lens in Myopia Progression Control
Date: 30/04/2024 (AEST)
Venue: Live Webinar - Register Here: https://us06web.zoom.us/webinar/register/WN_Zq8PJiAjSxmTAKtk7_plnA
Provider: Mivision
Activity Outline
The patients we see
in our clinics often fall outside the criteria for inclusion in randomised
clinical trials (RCTs), so how can we be confident that the results of a trial
will be just as relevant to these patients? Comparing data from both RCTs and
studies in the real world give us confidence to know we are making a fully
informed decision about the intervention we choose to manage our myopic
children.
Dr Brett O’Connor
will present the PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial)
1-year interim RCT data from the from Visioneering Technologies Inc. ongoing multi-national,
double-masked, randomised controlled trial (RCT). Dr O’Connor will share the
efficacy, visual performance and safety of NaturalVue as a myopia progression
intervention.
Dr Emma Gillies
will present a comparison of NaturalVue 6-year data published in Clinical
Ophthalmology (2022)1 and two other independent studies published in
20232,3 with the RCT data,
exploring the consistency in the data in diverse study groups.
60 mins presentations with 15 min Q&A
Register Here: https://us06web.zoom.us/webinar/register/WN_Zq8PJiAjSxmTAKtk7_plnA
Learning Objectives
- Understand the catenary curve design of the NaturalVue extended depth of focus soft contact lens design and how the unique power profile design slows myopic progression in children
- Appreciate the impact of NaturalVue as a myopia management intervention from the results of the multi-centre international RCT
- Understand the importance of evaluating a myopia management intervention using both RCT and real world data
Max CPD hours awarded: 1.25
Session Information
Name |
---|
PROTECT 12 Month RCT Data – Impact of a Unique EDOF Lens in Myopia Progression Control |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.25 |